Pseudomonas aeruginosa in the ICU: Prevalence, resistance profile, and antimicrobial consumption

dc.contributor.authorRibeiro A.C.D.S.
dc.contributor.authorCrozatti M.T.L.
dc.contributor.authorda Silva A.A.
dc.contributor.authorMacedo R.S.
dc.contributor.authorMachado A.M.O.
dc.contributor.authorSilva A.T.A.
dc.date.accessioned2024-03-12T23:50:32Z
dc.date.available2024-03-12T23:50:32Z
dc.date.issued2020
dc.description.abstract© 2020, Sociedade Brasileira de Medicina Tropical. All rights reserved.Introduction: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. Methods: Data were obtained from ICUs between 2010 and 2013. Results: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. Conclusions: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial-and multidrug resistance.
dc.description.volume53
dc.identifier.doi10.1590/0037-8682-0498-2018
dc.identifier.issn0037-8682
dc.identifier.urihttps://dspace.mackenzie.br/handle/10899/35126
dc.relation.ispartofRevista da Sociedade Brasileira de Medicina Tropical
dc.rightsAcesso Aberto
dc.subject.otherlanguageAntimicrobial agents
dc.subject.otherlanguageDrug resistance
dc.subject.otherlanguagePseudomonas aeruginosa
dc.titlePseudomonas aeruginosa in the ICU: Prevalence, resistance profile, and antimicrobial consumption
dc.typeArtigo
local.scopus.citations15
local.scopus.eid2-s2.0-85076930560
local.scopus.subjectAnti-Bacterial Agents
local.scopus.subjectCross Infection
local.scopus.subjectDrug Resistance, Multiple, Bacterial
local.scopus.subjectHumans
local.scopus.subjectIntensive Care Units
local.scopus.subjectMicrobial Sensitivity Tests
local.scopus.subjectPrevalence
local.scopus.subjectPseudomonas aeruginosa
local.scopus.subjectPseudomonas Infections
local.scopus.updated2024-05-01
local.scopus.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076930560&origin=inward
Arquivos